Ataluren is a protein restoration therapy designed to enable the formation of full-length, functional cystic fibrosis transmembrane regulator (CFTR) protein in patients with cystic fibrosis due to a
The Insulin agreement includes $57.5m in potential product development and sales milestone payments to Emisphere, of which $5m will be payable upon signing, as well as royalties on
The extended collaboration comes as the Japanese company intends to take a lead candidate into preclinical development, within the area of inflammation. The lead candidate was discovered using
The new patent, number 7,851,506, is also listed in the US Food and Drug Administration’s Approved Drug Products List (the Orange Book). In addition to the newly issued
Takeda filed the lawsuits to enforce several patents that expire in 2016 relating to ACTOS, ACTOplus met, and duetact. Agreements have been reached with: Mylan, Alphapharm, Watson Pharmaceuticals,
The agreement, in the areas of high-technology and knowledge sharing, will entail licensing of manufacturing know-how of products by Dr Reddy’s, local manufacturing of products in Russia, co-development
Tanaproget is a tissue-selective, non-steroidal contraceptive progesterone receptor agonist that has the potential for an improved side effect profile over current steroid-containing contraceptives. The tie up allows the
Morganroth is currently working as ERT’s chairman and chief scientific officer and has served as the chairman of ERT’s board of directors since 1999 and as chief scientific
The application relates to the use of Ergothioneine compositions containing one or more additional nutraceutical compounds to improve a variety of health related factors, including, but not limited
Janssen-Cilag International has also filed a marketing authorisation application (MAA) with the European Medicines Agency for abiraterone acetate. Abiraterone acetate was developed by Ortho Biotech Oncology Research &
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.